D. E. Shaw & Co., Inc. Regenxbio Inc. Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in Regenxbio Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 55,106 shares of RGNX stock, worth $434,235. This represents 0.0% of its overall portfolio holdings.

Number of Shares

55,106

Holding current value

$434,235

% of portfolio

0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$10.49 - $14.39 $918,535 - $1.26 Million	-87,563 Reduced 61.37%	55,106 $578,000
Q2 2024 Aug 14, 2024	SELL	$11.51 - $21.53 $155,281 - $290,461	-13,491 Reduced 8.64%	142,669 $1.67 Million
Q1 2024 May 15, 2024	SELL	$12.17 - $24.61 $18,011 - $36,422	-1,480 Reduced 0.94%	156,160 $3.29 Million
Q4 2023 Feb 14, 2024	BUY	$12.89 - $20.82 $1.46 Million - $2.35 Million	113,012 Added 253.23%	157,640 $2.83 Million
Q3 2023 Nov 14, 2023	BUY	$16.46 - $19.99 $734,576 - $892,113	44,628 New	44,628 $734,000
Q4 2022 Feb 14, 2023	SELL	$20.4 - $24.73 $85,680 - $103,866	-4,200 Reduced 25.53%	12,249 $277,000
Q3 2022 Nov 14, 2022	BUY	$22.29 - $35.04 $366,648 - $576,372	16,449 New	16,449 $435,000
Q4 2021 Feb 14, 2022	SELL	$30.19 - $40.28 $1.82 Million - $2.43 Million	-60,303 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$29.09 - $45.68 $5.86 Million - $9.2 Million	-201,467 Reduced 76.96%	60,303 $2.53 Million
Q2 2021 Aug 16, 2021	BUY	$32.46 - $40.48 $179,990 - $224,461	5,545 Added 2.16%	261,770 $10.2 Million
Q1 2021 May 17, 2021	BUY	$33.61 - $49.95 $3.73 Million - $5.54 Million	110,838 Added 76.24%	256,225 $8.74 Million
Q4 2020 Feb 16, 2021	BUY	$26.52 - $49.35 $262,760 - $488,959	9,908 Added 7.31%	145,387 $6.6 Million
Q3 2020 Nov 16, 2020	BUY	$27.01 - $40.26 $767,029 - $1.14 Million	28,398 Added 26.52%	135,479 $3.73 Million
Q2 2020 Aug 14, 2020	BUY	$27.75 - $43.44 $413,974 - $648,037	14,918 Added 16.19%	107,081 $3.94 Million
Q1 2020 May 15, 2020	BUY	$21.5 - $54.2 $1.47 Million - $3.71 Million	68,402 Added 287.88%	92,163 $2.98 Million
Q4 2019 Feb 14, 2020	SELL	$34.54 - $44.87 $397,693 - $516,633	-11,514 Reduced 32.64%	23,761 $973,000
Q3 2019 Nov 14, 2019	SELL	$31.84 - $50.88 $290,540 - $464,280	-9,125 Reduced 20.55%	35,275 $1.26 Million
Q2 2019 Aug 14, 2019	BUY	$42.0 - $59.29 $1.86 Million - $2.63 Million	44,400 New	44,400 $2.28 Million
Q4 2017 Feb 14, 2018	SELL	$26.0 - $34.6 $247,416 - $329,253	-9,516 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$18.0 - $32.95 $171,288 - $313,552	9,516	9,516 $314,000

Others Institutions Holding RGNX

# of Institutions

193

Shares Held

43.2M

Call Options Held

104K

Put Options Held

478K

View Full List

About REGENXBIO Inc.

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $341M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

More about RGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account